About 1 result found for searched term "Frovocimab" (0.124 seconds)
Cat.No. | Name | Target |
---|---|---|
M24769 | Frovocimab | PCSK9 |
LY 3015014 | ||
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody (mAb) that neutralizes PCSK9. Frovocimab inhibits PCSK9 binding to LDL receptor (LDLR) while permitting the normal proteolytic cleavage of the bound intact PCSK9. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.